Détail de l'auteur
Documents disponibles écrits par cet auteur (7)
Ajouter le résultat à ma sélection Faire une suggestion Affiner la recherche
Article
BENTLEY (Tanya-Gk) : USA. Faculty of Arts and Sciences. Harvard University. Cambridge. MA. ; Karen-M KUNTZ ; Milton-C WEINSTEIN ; WILLETT (Walter-C) : USA. Departments of Nutrition and Epidemiology. Harvard School of Public Health. And the Channing Laboratory. Department of Medicine. Brigham and Women's Hospital and Harvard Medical School. Boston. MA. ; Harvard School of Public Health. Department of Health Policy and Management. Boston. USA |[BDSP. Notice produite par INIST-CNRS xJHjR0xy. Diffusion soumise à autorisation]. Objectives. We sought to quantify the impact of the 1998 US Food and Drug Administration (FDA) folic acid fortification policy by estimating folate intake at the [...]
Article
Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population.
SALOMON (Joshua-A) : USA. Harvard Center for Population and Development Studies. Cambridge. MA. ; Sue-J GOLDIE ; James-K HAMMITT ; Milton-C WEINSTEIN |[BDSP. Notice produite par INIST-CNRS rNR0xxRk. Diffusion soumise à autorisation]. Context : Approximately 2.7 million US individuals are chronically infected with the hepatitis C virus (HCV). As public health campaigns are pursued, a growing nu[...]
Article
SALOMON (Joshua-A) : CHE. Global Programme on Evidence for Health Policy. World Health Organization. Geneva. ; Sue-J GOLDIE ; James-K HAMMITT ; Milton-C WEINSTEIN ; Harvard Center for Risk Analysis. Department of Health Policy and Management. Harvard School of Public Health. Boston. MA. USA |[BDSP. Notice produite par INIST-CNRS 78R0x0r7. Diffusion soumise ... autorisation]. This study presents a comprehensive epidemiologic model of hepatitis C in the United States. Through empirical calibration of model parameter values, the object[...]
Article
Joshua-S BENNER ; Jerry AVORN ; Robert-J GLYNN ; Helen MOGUN ; Peter-J NEUMANN ; Milton-C WEINSTEIN ; Center for Risk Analysis. Harvard School of Public Health. Boston. MA. USA ; Division of Pharmacoepidemiology & Pharmacoeconomics. Department of Medicine. Brigham and Women's Hospital and Harvard Medical School. Boston Mass. EGY |[BDSP. Notice produite par INIST-CNRS R0xy55iB. Diffusion soumise à autorisation]. Context Knowledge of long-term persistence with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) therapy is limited because previous studies hav[...]
Article
Bruce-R SCHACKMAN ; Kenneth-A FREEDBERG ; Sue-J GOLDIE ; HONG ZHANG . (.) ; Elena LOSINA ; Milton-C WEINSTEIN ; Center for Risk Analysis. Department of Health Policy and Management. Harvard School of Public Health. Boston. MA. USA ; Department of Epidemiology and Biostatistics. Boston University School of Public Health. Boston. USA |[BDSP. Notice produite par INIST-CNRS plMR0xe3. Diffusion soumise à autorisation]. Objectives. This study was designed to examine the societal cost-effectiveness and the impact on government payers of earlier initiation of antiretroviral therapy[...]
Article
Jeffrey-A TICE ; Pamela-G COXSON ; Paula-A GOLDMAN ; L.E.E. GOLDMAN ; Mgmyriam HUNINK ; Irwin ROSENBERG ; Elizabeth ROSS ; Milton-C WEINSTEIN ; Lawrence Williams ; Department of Health Policy and Management. Harvard School of Public Health. Boston. MA. USA ; Department of Medicine. University of California. San Francisco. USA ; Division of Clinical Nutrition. Tufts University. Boston. MA. USA |[BDSP. Notice produite par INIST-CNRS HDR0xMla. Diffusion soumise à autorisation]. Context A high homocysteine level has been identified as an independent modifiable risk factor for coronary heart disease (CHD) events and death. Since January 19[...]
Article
Kathryn-A PHILLIPS ; P.A.M. COXSON ; Paula-A GOLDMAN ; L.E.E. GOLDMAN ; Paul-A HEIDENREICH ; Mcmyriam HUNINK ; Michael-G SHLIPAK ; Milton-C WEINSTEIN ; Lawrence-W Williams ; Department of Health Policy and Management. Harvard School of Public Health. Boston Mass. NLD ; Department of Medicine. University of Californi. San Francisco. USA |[BDSP. Notice produite par INIST yR0x9EeR. Diffusion soumise à autorisation]. Context bêta-Blockers are underused in patients who have myocardial infarction (MI), despite the proven efficacy of these agents. New evidence indicates that bêta-bloc[...]
